I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Image_1_A tumor-restricted glycoform of podocalyxin is a hi..:
Julyanne Brassard
;
Michael R. Hughes
;
Pamela Dean
...
doi:10.3389/fonc.2023.1286754.s002. , 2023
Link:
https://doi.org/10.3389/fonc.2023.1286754.s002
RT Journal T1
Image_1_A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma.tiff
UL https://suche.suub.uni-bremen.de/peid=base-ftfrontimediafig:oai:figshare.com:article_24883728&Exemplar=1&LAN=DE A1 Julyanne Brassard A1 Michael R. Hughes A1 Pamela Dean A1 Diana Canals Hernaez A1 Shelby Thornton A1 Allyson C. Banville A1 Julian Smazynski A1 Mary Warren A1 Kevin Zhang A1 Katy Milne A1 C. Blake Gilks A1 Anne-Marie Mes-Masson A1 David G. Huntsman A1 Brad H. Nelson A1 Calvin D. Roskelley A1 Kelly M. McNagny YR 2023 K1 Cancer K1 Cancer Cell Biology K1 Cancer Diagnosis K1 Cancer Genetics K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Chemotherapy K1 Haematological Tumours K1 Molecular Targets K1 Radiation Therapy K1 Solid Tumours K1 Oncology and Carcinogenesis not elsewhere classified K1 podocalyxin K1 glycoepitope K1 immune cold K1 high-grade serous ovarian carcinoma K1 immunotherapy JF doi:10.3389/fonc.2023.1286754.s002 LK http://dx.doi.org/https://doi.org/10.3389/fonc.2023.1286754.s002 DO https://doi.org/10.3389/fonc.2023.1286754.s002 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)